Steve Sang-Woo Han

Title: Steve Sang-Woo Han: Innovator in Neurofilament Protein Research

Introduction

Steve Sang-Woo Han is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of medical research, particularly in the area of amyotrophic lateral sclerosis (ALS). His innovative work focuses on therapeutic interventions that can alleviate symptoms in patients suffering from this debilitating condition.

Latest Patents

Steve Sang-Woo Han holds a patent for a method involving neurofilament protein for guiding therapeutic intervention in amyotrophic lateral sclerosis. The patent describes a method for alleviating symptoms in ALS patients by administering an efficacious therapeutic. This therapeutic results in a lower level of neurofilament protein in a biological sample of the patient compared to those not receiving the treatment. This innovative approach has the potential to significantly improve the quality of life for ALS patients.

Career Highlights

Steve is currently employed at Biogen MA Inc., a leading biotechnology company known for its focus on neurological diseases. His work at Biogen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research that aims to develop effective treatments for ALS and other neurological disorders.

Collaborations

Steve has worked alongside talented colleagues such as Toby Arlo Ferguson and Danielle LeeZetta Graham. Their combined expertise fosters a collaborative environment that enhances the research and development of innovative therapies.

Conclusion

Steve Sang-Woo Han's contributions to the field of neurofilament protein research exemplify the impact of innovation in medical science. His work not only advances our understanding of ALS but also paves the way for new therapeutic strategies that can improve patient outcomes.